Loading organizations...
§ Private Profile · Shanghai, Shanghai, China
Tumor infiltration lymphocytes immunotherapy for solid tumors.
GRIT Biotechnology has raised $60.0M across 1 funding round.
GRIT Biotechnology has raised $60.0M in total across 1 funding round.
GRIT Biotechnology has raised $60.0M in total across 1 funding round.
GRIT Biotechnology's investors include CICC Capital, Decheng Capital, HeFangTian Venture Partnership, Liando Investment, Matrix Partners China, Sherpa Healthcare Partners, Yuanhe Capital.
GRIT Biotechnology has raised $60.0M across 1 funding round. Most recently, it raised $60.0M Series B in September 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 8, 2023 | $60M Series B | CICC Capital | Decheng Capital, Hefangtian Venture Partnership, Liando Investment, Matrix Partners China, Sherpa Healthcare Partners, Yuanhe Capital | Announced |